Collaborations and Interfaces

Academia, industry, patient groups, regulators, and the NHS/other healthcare systems all have important parts to play in the development of new treatments, be they drugs, devices or other new therapies.


CASMI’s work explores the interfaces between these organisations, from the cultures and incentives inherent within them to the clusters and collaborations that form between them.